VR-Assisted Exercise for Symptom Management and Rehabilitation in Interstitial Lung Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Manitoba

About this trial

This project aims to create and improve a VR-based breathing exercise program for patients with interstitial lung diseases (ILDs). It involves three phases: (1) developing an interactive VR application with guided breathing exercises and real-time biofeedback tailored for ILD patients, (2) testing its feasibility by evaluating usability and acceptability, and (3) refining the intervention based on feedback from the feasibility study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

≥ 18 years old

able to understand English

diagnosed with Interstitial Lung Disease (ILD)

Disqualifiers

experiencing acute exacerbation of their condition

being unable to provide informed consent

being unable to participate in a VR-based intervention

Trial design

Design model

Crossover

Treatments tested in this trial

  • Flyer

    Other intervention

    Participants will engage in slow, controlled diaphragmatic breathing exercises, box breathing, and arm exercises at home using printed instructions as guide.

  • VR-based

    Other intervention

    Participants will engage in guided breathing exercises and arm exercises delivered through an immersive VR application. The intervention will be performed while seated comfortably and will follow a progressive training schedule consisting of supervised laboratory sessions and independent home-based sessions.

Treatment groups

32 Participants
are divided into 2 treatment groups
Group A: VR-based Breathing ExerciseExperimental treatment 1 intervention
Group B: Breathing Exercises using Printed MaterialsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Dyspnea

The Medical Research Council scale is a five-point grading system (1 to 5) used to classify the degree of activity limitation caused by dyspnea, wherein a grade 1 represents the lowest level of breathlessness and a grade 5 represents the highest level of breathlessness and activity limitation.

Time frame
4 weeks
2

Fatigue Severity Scale

Measures the severity of fatigue and its effects on a person's activities and lifestyle in patients with a variety of disorders using a 9-item questionnaire that measures how fatigue affects daily activities. Each item is rated on a 7-point scale wherein a score of 1 means strongly disagree, while a score of 7 means strongly agree. This means that a lower scores indicate less fatigue and a higher scores indicate more severe fatigue.

Time frame
4 weeks
3

1-minute sit-to-stand

The 1-Minute Sit-to-Stand Test is used to evaluate exercise tolerance in patients with chronic respiratory diseases. It measures lower-limb strength, endurance, and cardiorespiratory fitness by counting the repetitions of sit-to-stand completed within 60 seconds.

Time frame
4 weeks
4

Change in Health Related Quality of Life

Assessed using the St George's Respiratory Questionnaire which is a standardized questionnaire for measuring impaired health and perceived well-being ("quality of life") in airways disease. Scores range from 0 to 100, with higher scores indicating more limitations.

Time frame
4 weeks

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Manitoba

Lead sponsor

Canadian Lung Association

Collaborator

This trial is not recruiting at the moment. You can still explore other options: